Leukemia, Lymphoma and Myeloma

Hematologic cancers are malignancies impacting the body’s blood, bone marrow or lymph system. There are more than two dozen hematologic disorders, each with a unique set of symptoms and options for treatment. The University of Michigan Comprehensive Cancer Center offers a number of clinics and cutting-edge programs to best meet your needs:

• The Hematology/Oncology Clinic – provides comprehensive care for patients with benign and malignant disorders of the hematopoietic system (cancers of the blood and marrow, such as leukemia, blood disorders, multiple myeloma and myeloproliferative disorders).
• Multidisciplinary Lymphoma Clinic – a comprehensive clinic for patients with newly-diagnosed and recurrent lymphoma. The most common forms of lymphoma are Hodgkin's and non-Hodgkin's lymphoma.
• Cutaneous Lymphoma Clinic – provides comprehensive and collaborative interdisciplinary care for patients diagnosed with cutaneous lymphomas.

All clinics are staffed by multidisciplinary teams, making it possible for patients to be seen by all disciplines in one appointment to expedite diagnosis and the determination of individualized treatment plans. Because our clinical faculty members are active participants in basic and clinical research studies, both within the University and nationally, hematologic cancer patients treated at the University of Michigan have access to both standard therapies and investigational treatments, including clinical trials.

The Accredited University of Michigan Blood and Marrow Transplantation Program

The Blood and Marrow Transplantation Program one of the largest in the country, is internationally known for its research into novel approaches to make transplantation safer and more effective. The program is accredited by the Foundation for Accreditation of Hematopoietic Cell Therapy and is also approved by the National Marrow Donor Program, the Southwest Oncology Group and the Children's Cancer Group.

Each year an estimated 30,000 Americans, including more than 1,000 Michigan residents, are diagnosed with life-threatening diseases that can now be treated successfully by transplanting bone marrow or blood stem cells.